BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2025-02

141 industry Phase 2/3 trial readout(s) and 32 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2025-01 | 2025-03 →

FDA decision events

DateEventStatusCompanyDrugSource
2025-02-02FDA approvalapprovedWELDERS SUPPLY COMPANY OF LOUISVILLE INCCarbon Dioxide USPApproved 2025-02-02: Carbon Dioxide, USP (NDA220266 ORIG1)
2025-02-03FDA approvalapprovedGENENTECH INCSUSVIMOApproved 2025-02-03: SUSVIMO (BLA761197 SUPPL6)
2025-02-03FDA approvalapprovedMDD USONAPGOApproved 2025-02-03: ONAPGO (NDA214056 ORIG1)
2025-02-05FDA AdComheldAdCom 2025-02-05: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee
2025-02-07FDA approvalapprovedMDGHMOXIDECTINApproved 2025-02-07: MOXIDECTIN (NDA210867 SUPPL6)
2025-02-07FDA approvalapprovedABBVIE ABBVEMBLAVEOApproved 2025-02-07: EMBLAVEO (NDA217906 ORIG1)
2025-02-11FDA approvalapprovedGENENTECH INCEVRYSDIApproved 2025-02-11: EVRYSDI (NDA219285 ORIG1)
2025-02-11FDA approvalapprovedSPRINGWORKSGOMEKLIApproved 2025-02-11: GOMEKLI (NDA219379 ORIG1)
2025-02-11FDA approvalapprovedSPRINGWORKSGOMEKLIApproved 2025-02-11: GOMEKLI (NDA219389 ORIG1)
2025-02-11FDA approvalapprovedSEATTLE GENETICSADCETRISApproved 2025-02-11: ADCETRIS (BLA125388 SUPPL108)
2025-02-12FDA approvalapprovedASTELLASIZERVAYApproved 2025-02-12: IZERVAY (NDA217225 SUPPL1)
2025-02-13FDA approvalapprovedSAMSUNG BIOEPIS CO LTDDENOSUMAB-DSSB; OSPOMYV; XBRYKApproved 2025-02-13: DENOSUMAB-DSSB; OSPOMYV; XBRYK (BLA761392 ORIG1)
2025-02-14FDA approvalapprovedDECIPHERA PHARMSROMVIMZAApproved 2025-02-14: ROMVIMZA (NDA219304 ORIG1)
2025-02-14FDA approvalapprovedSANOFI-AVENTIS U.S. LLC SNYMERILOG; MERILOG SOLOSTARApproved 2025-02-14: MERILOG; MERILOG SOLOSTAR (BLA761325 ORIG1)
2025-02-19FDA approvalapprovedCIPLANILOTINIB D-TARTRATEApproved 2025-02-19: NILOTINIB D-TARTRATE (NDA218922 ORIG1)
2025-02-19FDA approvalapprovedGILEAD SCIENCES INC GILDODEFSEYApproved 2025-02-19: ODEFSEY (NDA208351 SUPPL15)
2025-02-19FDA approvalapprovedGILEAD SCIENCES INC GILDODEFSEYApproved 2025-02-19: ODEFSEY (NDA208351 SUPPL14)
2025-02-20FDA AdComheldAdCom 2025-02-20: General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee
2025-02-21FDA approvalapprovedPFIZER PFEXELJANZApproved 2025-02-21: XELJANZ (NDA213082 SUPPL10)
2025-02-21FDA approvalapprovedPF PRISM CVXELJANZApproved 2025-02-21: XELJANZ (NDA203214 SUPPL38)
2025-02-21FDA approvalapprovedPFIZER PFEXELJANZApproved 2025-02-21: XELJANZ XR (NDA208246 SUPPL25)
2025-02-21FDA approvalapprovedHQ SPCLT PHARMADILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDEApproved 2025-02-21: DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE (NDA218038 ORIG1)
2025-02-21FDA approvalapprovedMIRUM MIRMCTEXLIApproved 2025-02-21: CTEXLI (NDA219488 ORIG1)
2025-02-21FDA approvalapprovedINDIVIORSUBLOCADEApproved 2025-02-21: SUBLOCADE (NDA209819 SUPPL31)
2025-02-24FDA AdComheldNovartis Pharmaceuticals Corporation NVSAdCom 2025-02-24: Cardiovascular and Renal Drugs Advisory Committee - sNDA 218276
2025-02-24FDA approvalapprovedSEBELA WOMENS HLTHMIUDELLAApproved 2025-02-24: MIUDELLA (NDA218201 ORIG1)
2025-02-28FDA approvalapprovedGENENTECHTNKASEApproved 2025-02-28: TNKASE (BLA103909 SUPPL5197)
2025-02-28FDA approvalapprovedALEXION PHARMSOLIRISApproved 2025-02-28: SOLIRIS (BLA125166 SUPPL448)
2025-02-28FDA approvalapprovedBAXTER HLTHCARE CORP BAXEPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDEApproved 2025-02-28: EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NDA218475 ORIG1)
2025-02-28FDA approvalapprovedCELLTRION INCOSENVELT; STOBOCLOApproved 2025-02-28: OSENVELT; STOBOCLO (BLA761404 ORIG1)
2025-02-28FDA approvalapprovedACTELIONOPSUMITApproved 2025-02-28: OPSUMIT (NDA204410 SUPPL29)
2025-02-28FDA approvalapprovedASTRAZENECA UK LTD AZNIMFINZIApproved 2025-02-28: IMFINZI (BLA761069 SUPPL51)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-02P3BioCardia, Inc. BCDANCT02438306 CardiAMP™ Cell Therapy for Heart Failure TrialHeart Failure, Systoliccompleted125
2025-02 est.P2Rocket Pharmaceuticals Inc. RCKTNCT04069533 Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype AFanconi Anemia Complementation Group Aunknown7
2025-02 est.P2Imbria Pharmaceuticals, Inc.NCT04306237 A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory AnginaRefractory Anginawithdrawn
2025-02 est.P2EMSNCT04666701 Efficacy and Safety of Escócia Association in the Treatment of Acute PainAcute Painwithdrawn
2025-02 est.P1/P2NGM Biopharmaceuticals, IncNCT04913337 Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesMesothelioma; Glioblastoma; Renal Cell Carcinoma; Non Small Cell Lung Cancer; Melanoma; Pancreatic Dunknown179
2025-02 est.P1/P2Nimbus Saturn, Inc.NCT05128487 A Study of NDI 1150-101 in Patients With Solid TumorsSolid Tumor; Renal Cell Carcinoma (Kidney Cancer); Gastric and Gastroesophageal Junction (GEJ) Adenoactive not recruiting106
2025-02 est.P3Reviva Pharmaceuticals RVPHNCT05184335 Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaSchizophreniarecruiting690
2025-02 est.P2Beijing Konruns Pharmaceutical Co., Ltd.NCT05683886 A Study of KC1036 in Patients with Advanced Thymic TumorsThymic Tumorsunknown30
2025-02 est.P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05686629 An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus PneumoniaNovel COVID-19-Infected Pneumoniaunknown120
2025-02 est.P1/P2Immunophotonics, Inc.NCT05688280 Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STSMetastatic Solid Tumor; Colon Cancer; Nonsmall Cell Lung Cancer; Soft Tissue Sarcomaactive not recruiting42
2025-02 est.P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT05688839 A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus PneumoniaNovel COVID-19-Infected Pneumoniaunknown60
2025-02 est.P1/P2Cantex PharmaceuticalsNCT05766748 Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerMetastatic Pancreatic Cancerunknown30
2025-02 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05998941 A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical CanCervical Cancerwithdrawn
2025-02 est.P2Rivus Pharmaceuticals, Inc.NCT06104358 Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 DDiabete Type 2; Obesitywithdrawn
2025-02 est.P3Addpharma Inc.NCT06348576 Phase III Study to Evaluate the Efficacy and Safety of AD-209Hypertension,Essentialunknown280
2025-02-01 est.P1/P2Stem Cell Medicine Ltd. STEMNCT03696485 Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMSSecondary Progressive Multiple Sclerosis (SPMS)withdrawn
2025-02-01 est.P2Biozeus Biopharmaceutical S.A.NCT06116045 Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal DisorderFemale Sexual Arousal Disorder; Female Sexual Dysfunctionunknown30
2025-02-01P1/P2Vanarix SANCT06897111 Implantation of Cartilage Mini-grafts Made From Donor Cells to Treat Chondral Lesions of the KneeCartilage Repaircompleted10
2025-02-02P2/P3Janssen Research & Development, LLCNCT04119050 Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic AnemiaWarm Autoimmune Hemolytic Anemiaactive not recruiting118
2025-02-03P2Lytix Biopharma ASNCT04796194 Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced MelanomaAdvanced Melanomacompleted23
2025-02-03P2AbbVie ABBVNCT05216250 Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential TremorUpper Limb Essential Tremor (UL ET)completed174
2025-02-03P3Incyte Corporation INCYNCT05620823 A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativa (HS)completed608
2025-02-03P3RDC Clinical Pty LtdNCT05950841 Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal WomanIron-deficiencycompleted180
2025-02-03P2/P3AbbVie ABBVNCT06018987 A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial FoldsNasolabial Foldscompleted61
2025-02-03P2argenx ARGXNCT06203457 Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's SyndromePrimary Sjögren's Syndromecompleted24
2025-02-03P3Pfizer PFENCT06593587 A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in KoreaRespiratory Syncytial Viruscompleted378
2025-02-04P2Janssen Research & Development, LLCNCT04919512 A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the BladderUrinary Bladder Neoplasmscompleted163
2025-02-04P3Neurocrine Biosciences NBIXNCT05110157 Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for SchizophreniaSchizophreniacompleted442
2025-02-04P2/P3Novavax NVAXNCT06485752 Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza VaccineCOVID-19withdrawn
2025-02-05P2Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyNCT05001269 Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal FunctionPrimary Hyperoxaluria; Primary Hyperoxaluria Type 1; Primary Hyperoxaluria Type 2; Primary Hyperoxalcompleted27
2025-02-05P2Shanghai Pharmaceuticals Holding Co., LtdNCT05046314 A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's SarcomaSarcoma, Ewingcompleted15
2025-02-05P2/P3Camurus ABNCT05281328 A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLDPolycystic Liver Diseaseactive not recruiting71
2025-02-05P1/P2Barinthus BiotherapeuticsNCT05617040 Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerProstate Cancerterminated22
2025-02-05P2Novartis Pharmaceuticals NVSNCT05885555 A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of TherapiesPrimary Immune Thrombocytopenia (ITP)active not recruiting41
2025-02-05P3UCB Biopharma SRLNCT06011733 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque PsoriasisChronic Plaque Psoriasis; Moderate to Severe Chronic Plaque Psoriasiscompleted133
2025-02-05P1/P2Genmab GMABNCT06018129 A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin LymphomaClassical Hodgkin Lymphoma; Non-Hodgkin Lymphomaterminated9
2025-02-05P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06036927 A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal PolypsChronic Sinusitis; Nasal Polypscompleted80
2025-02-05P1/P2Pfizer PFENCT06436703 A Study About Modified RNA Vaccines Against Influenza in Healthy AdultsInfluenza, Humancompleted1202
2025-02-05P2Palatin Technologies, Inc PTNNCT06565611 A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityObesityactive not recruiting108
2025-02-06P1/P2BeiGeneNCT03744468 Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid TumorsLocally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in;completed147
2025-02-06P2Noema Pharma AGNCT05059327 Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSCTuberous Sclerosis Complexcompleted61
2025-02-06P2Sanofi SNYNCT06118099 Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitisterminated90
2025-02-06P1/P2Innostellar Biotherapeutics Co.,LtdNCT06212297 Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal DystrophyInherited Retinal Dystrophyactive not recruiting9
2025-02-06P2BioAge Labs, Inc. BIOANCT06515418 Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and OverObesityterminated204
2025-02-06P3Alcon Research ALCNCT06660290 A Study to Evaluate 0.003% AR-15512 Safety and Drop AttributesDry Eye Diseasecompleted55
2025-02-07P2Hoffmann-La RocheNCT03032172 A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular AtrophySpinal Muscular Atrophycompleted174
2025-02-07P2Novartis Pharmaceuticals NVSNCT05358717 A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington Diseasecompleted159
2025-02-07P2ACELYRIN Inc.NCT05384249 Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisUveitisterminated96
2025-02-07P3AstraZeneca AZNNCT05924880 A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With UnreseBiliary Tract Cancerscompleted116
2025-02-07P3Axsome Therapeutics, Inc. AXSMNCT05972044 A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)ADHDcompleted516
2025-02-10P3Jiangsu Simcere Pharmaceutical Co., Ltd.NCT04914598 A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural EffusionsMalignant Pleural Effusionactive not recruiting290
2025-02-10P2Palatin Technologies, Inc PTNNCT05466890 Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)Ulcerative Colitis; Ulcerative Colitis Acute; Ulcerative; Ulcerative Colitis Flareactive not recruiting16
2025-02-10 est.P2Changzhou Qianhong Bio-pharma Co., Ltd.NCT06532058 Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid Leukemia (R/R-AML)unknown53
2025-02-11P2IntraBio IncNCT03759678 N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)Ataxia Telangiectasiaterminated17
2025-02-11P3Nemysis LtdNCT06285799 Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal WomenIron-deficiencycompleted180
2025-02-12P2/P3Pfizer PFENCT01500551 Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic ArthritisJuvenile Idiopathic Arthritiscompleted302
2025-02-12P3UCB Biopharma SRLNCT04627285 A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received LacoEpilepsycompleted48
2025-02-12P2AbbVie ABBVNCT04958031 A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related ApathyApathy in Dementiaterminated41
2025-02-12P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT05002270 JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C MutationAdvanced Solid Tumor; NSCLC; CRCcompleted29
2025-02-12P2Cothera Bioscience, IncNCT05263583 Sepantronium Bromide for the Treatment of High-grade B-cell LymphomaHigh-grade B-cell Lymphoma; Burkitt Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymcompleted14
2025-02-12P1/P2Alentis Therapeutics AGNCT06054477 Study of ALE.C04 in Patients With Head and Neck CancerHead and Neck Cancer; Head and Neck Squamous Cell Carcinomaterminated21
2025-02-12P2Sanofi SNYNCT06067425 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With AchondroplasiaOsteochondrodysplasiaterminated16
2025-02-13P2Pfizer PFENCT05090566 MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple MyelomaMultiple Myelomaterminated46
2025-02-13P2/P3Pfizer PFENCT05632354 GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)Sickle Cell Diseaseterminated47
2025-02-13P3Sinovac Biotech Co., Ltd SVANCT05850364 A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV VaccinePoliomyelitis; Poliocompleted1442
2025-02-13P3Nanjing Zenshine PharmaceuticalsNCT06099873 Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With InfluenzaRespiratory Viral Infectioncompleted361
2025-02-13P2Shanghai Huaota Biopharmaceutical Co., Ltd.NCT06231381 Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)Generalized Pustular Psoriasis (GPP)recruiting33
2025-02-14P1/P2Eli Lilly and Company LLYNCT03157128 A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Non-Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Any Solid Tumoractive not recruiting857
2025-02-14P2/P3ACADIA Pharmaceuticals Inc. ACADNCT05555615 Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum DisorderIrritability Associated With Autism Spectrum Disorderterminated209
2025-02-14P2Vigil Neuroscience, Inc.NCT05677659 A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented GliaALSPterminated20
2025-02-14P3Merck Sharp & Dohme LLC MRKNCT06450366 A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic AHypercholesterolemiacompleted301
2025-02-14P1/P2Biomind Labs Inc.NCT06816667 Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and AnxietyHealthy Volunteerscompleted40
2025-02-15P1/P2ImmunityBio, Inc. IBRXNCT05304936 HCW9218 for Advanced Pancreatic CancerAdvanced Pancreatic Carcinomacompleted21
2025-02-15 est.P2Ethos Research & DevelopmentNCT06247813 Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic PainChronic Painunknown75
2025-02-15P1/P2Biomind Labs Inc.NCT06812221 Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCIMild Cognitive Impairment; Anxiety State; Depression Anxiety Disordercompleted20
2025-02-17P3Hoffmann-La RocheNCT05171647 A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus OxaliNon-Hodgkin Lymphomaactive not recruiting208
2025-02-17P2Novo Nordisk A/S NVONCT05442047 A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) AmyloidTransthyretin Amyloid Cardiomyopathy (ATTR CM)completed105
2025-02-17P3CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.NCT05997576 A Study of TG103 Injection in Non-diabetic Overweight or ObesityOverweight or Obesitycompleted675
2025-02-17P2Jiangsu HengRui Medicine Co., Ltd.NCT06035393 A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Diseaseterminated82
2025-02-17P3Axsome Therapeutics, Inc. AXSMNCT06736509 An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyAgitation in Patients With Dementia of the Alzheimer's Type; Alzheimer Disease; Agitation, Psychomotterminated139
2025-02-18P2AstraZeneca AZNNCT04564027 A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerAdvanced Solid Tumourscompleted54
2025-02-18P3Curium US LLCNCT06235099 Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerProstate Cancer; Prostate Adenocarcinoma; Biochemical Recurrence of Malignant Neoplasm of Prostatecompleted235
2025-02-18P3Chiesi Farmaceutici S.p.A.NCT06264674 Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).Asthmacompleted827
2025-02-18P3Espad PharmedNCT06946160 A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for CorreGlabellar Lines; Glabellar Frown Linescompleted146
2025-02-19P1/P2Bristol-Myers Squibb BMYNCT03459222 An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have SpreadAdvanced Cancercompleted229
2025-02-19P1/P2Transcend TherapeuticsNCT05741710 A Study to Assess the Use of Methylone in the Treatment of PTSDPost Traumatic Stress Disordercompleted79
2025-02-19P1/P2Innovent Biologics (Suzhou) Co. Ltd.NCT06170190 A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumoursLocally Advanced Unresectable or Metastatic Solid Tumorscompleted19
2025-02-19P3AkesoNCT06378697 A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing SpondylitisAnkylosing Spondylitiscompleted510
2025-02-19P3CanSino Biologics Inc.NCT06700148 A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year OldsMeningococcal Meningitiscompleted840
2025-02-20P3Jiangsu Aosaikang Pharmaceutical Co., Ltd.NCT07739368 Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel DiseaseIron Deficiency Anaemiacompleted122
2025-02-21P3Vanda Pharmaceuticals VNDANCT04028492 Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic GastroparesisIdiopathic Gastroparesis; Diabetic Gastroparesis; Gastroparesiscompleted979
2025-02-21P3Protagonist Therapeutics, Inc. PTGXNCT05210790 A Study of Rusfertide in Adults With Polycythemia Vera (PV)Polycythemia Veraactive not recruiting293
2025-02-21P3Beijing Mabworks Biotech Co., Ltd.NCT05314010 A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)Neuromyelitis Optica Spectrum Disorderactive not recruiting102
2025-02-21 est.P3Qilu Pharmaceutical (Hainan) Co., Ltd.NCT06446310 Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusUremic Pruritusunknown194
2025-02-22P2Sanotize Research and Development corp.NCT06264141 Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute RhinosinusitisRecurrent Acute Rhinosinusitiscompleted162
2025-02-24P2Amgen AMGNNCT04781543 A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic SclerosisDiffuse Cutaneous Systemic Sclerosis; Sclerosis, Systemicterminated301
2025-02-24P2Genentech, Inc.NCT05037929 A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Diseasecompleted1334
2025-02-24P2Amgen AMGNNCT05626751 An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)Diffuse Cutaneous Systemic Sclerosis; Sclerosis, Systemicterminated174
2025-02-24P1/P2AkesoNCT05636267 Study of AK119 and AK112 With or Without Chemotherapy for NSCLC PatientsNSCLCterminated59
2025-02-24P2Novartis Pharmaceuticals NVSNCT05816395 Safety and Efficacy of RHH646 for Knee OsteoarthritisOsteoarthritis, Kneecompleted82
2025-02-24P2Recursion Pharmaceuticals Inc. RXRXNCT06005974 A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationAXIN1 Gene Mutation; APC Gene Mutation; Solid Tumorterminated18
2025-02-24P2AbbVie ABBVNCT06151535 A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult ParticipantsSkin Quality Deficitcompleted30
2025-02-25P2Astellas Pharma Global Development, Inc.NCT04225117 A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Locally Advanced or Metastatic Malignant Solid Tumorsactive not recruiting329
2025-02-25P3Sumitomo Pharma Switzerland GmbHNCT04756037 Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for PregnancyContraceptioncompleted1164
2025-02-25 est.P2Amgen AMGNNCT05323617 Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive TherapySevere Aplastic Anemia (SAA)withdrawn
2025-02-25P2Veradermics, Inc. MANENCT05799157 Safety and Efficacy of VDMN-21 Patch in Subjects With Common WartsVerruca Vulgaris; Warts; Common Wartcompleted153
2025-02-26P3GlaxoSmithKlineNCT04475939 Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/MetastatiLung Cancer, Non-Small Cellcompleted666
2025-02-26P3AstraZeneca AZNNCT05202262 A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately ConAsthmacompleted645
2025-02-26P3Boehringer IngelheimNCT05211947 A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX StudySchizophreniaterminated1356
2025-02-26P2Alterity Therapeutics ATHENCT05864365 A Biomarker Study of ATH434 in Participants With MSAMultiple System Atrophycompleted10
2025-02-26P3Merck Sharp & Dohme LLC MRKNCT06177912 A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)Pneumococcal Infectioncompleted882
2025-02-26P2Boehringer IngelheimNCT06280235 A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive MedicineDepressive Disorder, Majorcompleted243
2025-02-26P3AbbVie ABBVNCT06308198 A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar LinesGlabellar Linescompleted161
2025-02-26P3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT07047196 Evaluating the Efficacy and Safety of Intra-articular Injection of HS-20116 in Patients With Knee OsteoarthritisKnee Osteoarthritiscompleted192
2025-02-27P1/P2Hoffmann-La RocheNCT03193190 A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)Pancreatic Adenocarcinomacompleted341
2025-02-27P3Regeneron Pharmaceuticals REGNNCT03409614 Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung CancerNon-small Cell Lung Cancercompleted789
2025-02-27P2Transposon Therapeutics, Inc.NCT05613868 TPN-101 in Aicardi-Goutières Syndrome (AGS)Aicardi-Goutières Syndrome (AGS)terminated4
2025-02-27P3Amgen AMGNNCT05704738 A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)Atopic Dermatitiscompleted532
2025-02-27P2Dongguan HEC Biopharmaceutical R&D Co., Ltd.NCT06148649 Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes MellitusType 2 Diabetescompleted234
2025-02-27P2Mineralys Therapeutics Inc. MLYSNCT06150924 Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (Chronic Kidney Diseasecompleted60
2025-02-27 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06242652 A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)Ankylosing Spondylitisunknown250
2025-02-27P3Aldeyra Therapeutics, Inc. ALDXNCT06493604 A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseDry Eye Diseasecompleted116
2025-02-27P2Biomed Industries, Inc.NCT06564753 Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid ConditionWeight Loss; Obesity; Body Weight; Body Weight Changescompleted126
2025-02-27P2Rose Pharma IncNCT06621017 Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese SubjectsObesity; Overweightcompleted40
2025-02-28P3Merck Sharp & Dohme LLC MRKNCT03903562 Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)Papillomavirus Infectionscompleted1990
2025-02-28P3Maggie's Pearl, LLCNCT04925960 Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDGPmm2-CDG; Phosphomannomutase 2 Deficiency; Phosphomannomutase 2 Congenital Disorder of Glycosylationterminated42
2025-02-28 est.P1/P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT04954001 Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis TypNeurofibromatosis 1; Plexiform Neurofibroma; NF1unknown160
2025-02-28P3Pharmbio Korea Co., Ltd.NCT05509868 Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South KoreaAcute Paincompleted182
2025-02-28 est.P1/P2RedCloud Bio RCTNCT05519293 Phase I/IIa Study of H002 in NSCLC With Active EGFR MutationNon-small Cell Lung Cancerunknown76
2025-02-28 est.P1/P2RedCloud Bio RCTNCT05552781 H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLCNon-small Cell Lung Cancerunknown76
2025-02-28P3Cytokinetics CYTKNCT05767346 Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCMObstructive Hypertrophic Cardiomyopathy (oHCM)completed175
2025-02-28 est.P3Sichuan Jishengtang Pharmaceutical Co., Ltd.NCT05772104 Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety DisorderGeneralized Anxiety Disorderrecruiting495
2025-02-28P3AkesoNCT05840016 AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung CancerAdvanced Squamous Non Small Cell Lung Canceractive not recruiting532
2025-02-28P2Incyte Corporation INCYNCT05936567 Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous UrticariaUrticaria; Chronic Spontaneous Urticaria; Chronic Idiopathic Urticaria; Hives; Angioedema; Pruritiscompleted136
2025-02-28 est.P2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT05937867 A Phase II Study of HS-10353 in Participants With Postpartum DepressionPostpartum Depressionunknown96
2025-02-28 est.P3Daewoong Pharmaceutical Co. LTD.NCT06025409 Evaluate the Efficacy and Safety of DWJ108JCentral Precocious Pubertyunknown79
2025-02-28P3Amgen AMGNNCT06122649 A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)Plaque Psoriasiscompleted203
2025-02-28 est.P1/P2Shenzhen TargetRx Co., Ltd.NCT06206174 TGRX-814 Chinese Phase I/II in Patients With Hematological MalignanciesHematologic Malignancy; Non Hodgkin Lymphoma; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia, recruiting30
2025-02-28P3Abbott ABTNCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional DyspepsiaFunctional Dyspepsiacompleted564
2025-02-28P2Priovant Therapeutics, Inc.NCT06433999 A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant DermatomyositisDermatomyositis; Dermatomyositis, Adult Typecompleted5
2025-02-28 est.P1/P2Primoris Therapeutics PRIMNCT06440239 A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s)Burns; Burn Degree Secondunknown40

← 2025-01 | 2025-03 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.